BIO-key International Inc. (NASDAQ:BKYI) Short Interest Update

BIO-key International Inc. (NASDAQ:BKYIGet Free Report) saw a large decrease in short interest in July. As of July 15th, there was short interest totaling 1,399 shares, a decrease of 68.4% from the June 30th total of 4,425 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 34,947 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, BIO-key International currently has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on BKYI

BIO-key International Stock Performance

BIO-key International stock opened at $4.40 on Friday. BIO-key International has a 52 week low of $3.10 and a 52 week high of $19.70. The stock has a market capitalization of $4.80 million, a P/E ratio of -0.79 and a beta of 0.43. The stock has a fifty day moving average of $4.47 and a 200-day moving average of $5.44.

Institutional Inflows and Outflows

A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its holdings in shares of BIO-key International Inc. (NASDAQ:BKYIFree Report) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

(Get Free Report)

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.

Featured Stories

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.